Clinical trial
A Rheumatoid Arthritis Study in Participants
NCT01202760
Study timeline
Study start (unknown)2011-01-01Date precision: month
Registry last updated2018-04-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
PhiladelphiaPennsylvania, United States1DallasTexas, United States1St LouisMissouri, United States1San AntonioTexas, United States1NashvilleTennessee, United States1SeoulSouth Korea1BirminghamAlabama, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1Oklahoma CityOklahoma, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01202760 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.